Cargando…
Textbook of autism spectrum disorders /
"More than 40 years after the official recognition of infantile autism in DSM-III, advances continue to be made in our understanding of the possible causes, assessment and evaluation, and treatment of autism spectrum disorder (ASD). With contributions by dozens of experts in the field, this sec...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, DC :
American Psychiatric Association Publishing,
[2022]
|
| Edición: | Second edition. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover
- Half Title
- Title
- Copyright
- Contents
- Contributors List
- Foreword
- PART I: Assessment, Evaluation, and Target Symptoms
- Part 1A: AASSESSMENT AND EVALUATION
- 1 Epidemiology
- 2 Psychiatric Assessment and Treatment
- 3 Pediatric and Neurological Assessments
- 4 Gender Dysphoria, Gender Incongruence, and Sexual Identity
- 5 Racial and Ethnic Disparities in Assessment and Evaluation
- 6 Digital Biomarkers in Diagnostics and Monitoring
- Part 1B: TARGET AND COMORBID SYMPTOMS
- 7 Social Communication
- 8 Diet and Nutrition
- PART II: Causes
- Part IIA: OVERVIEW
- 9 Genetics and Genomics
- 10 Epigenomics
- 11 Prenatal, Perinatal, and Parental Risk Factors
- 12 Animal Models
- 13 Electrophysiological Studies
- 14 Environmental Toxicity and Immune Dysregulation
- Part IIB: SYNDROMIC CAUSES
- 15 Overview of Syndromic Causes of ASD and Commonalities in Neurobiological Pathways
- 16 Fragile X Syndrome and Associated Disorders
- 17 Tuberous Sclerosis Complex
- 18 16p11.2 and Other Recurrent Copy Number Variants Associated With ASD Susceptibility
- 19 Rett Syndrome
- 20 Prader-Willi Syndrome
- Part IIC: IMAGING AND ANATOMY
- 21 Neuroanatomical Findings
- 22 The Amygdala in ASD
- 23 Neurobiology of ASD Informed by Structural Imaging Research
- 24 Positron Emission Tomography
- 25 Functional Magnetic Resonance Imaging
- PART III: Treatments and Interventions
- Part IIIA: STANDARD PHARMACOLOGICAL TREATMENTS
- 26 Serotonergic Medication
- 27 Antipsychotics
- 28 Treating Hyperactivity in Children With Pervasive Developmental Disorders
- Part IIIB: EXPERIMENTAL THERAPEUTICS
- 29 Complementary and Integrative Approaches
- 30 Oxytocin
- 31 Vasopressin
- 32 N-Acetylcysteine
- 33 Arbaclofen: From Animal Models to Clinical Trials
- 34 Cannabis, Cannabinoids, and Immunomodulatory Agents
- Part IIIC: BEHAVIORAL AND EDUCATIONAL INTERVENTIONS
- 35 Behavioral Treatments
- 36 Early Start Denver Model
- 37 The Developmental, Individual Difference, Relationship-Based Intervention Model: A Comprehensive Parent-Mediated Approach
- 38 School-Based Interventions
- 39 Language and Communication: Challenges and Treatments
- Part IIID: FUTURE TREATMENT DEVELOPMENTS
- 40 Transcranial Magnetic Stimulation
- 41 Stem Cell and Gene Therapy
- 42 Gene Therapy and Molecular Interventions
- PART IV: Consortiums, Employment, and Advocacy
- 43 Consortiums
- Developing Precision Medicine Approaches to ASD
- Autism Biomarkers Consortium for Clinical Trials
- Interactive Autism Network
- 44 Autism Strengths and Neurodiversity
- 45 Role of Patient Advocacy Groups in Treatment Development
- Index
- Plates
- Back Cover